Why the study?
To quantify pancreatic fat content in patients with newly diagnosed type 2 diabetes mellitus using proton magnetic resonance spectroscopy.
Does pancreatic fat content measured by proton magnetic resonance spectroscopy differ between newly diagnosed T2DM patients and non-diabetic controls?
Does pancreatic fat content measured by proton magnetic resonance spectroscopy differ between newly diagnosed T2DM patients and non-diabetic controls?
Pancreatic fat content measured by proton magnetic resonance spectroscopy does not significantly differ between newly diagnosed T2DM patients and non-diabetic controls.
Pancreatic fat quantification by MRS in new T2DM should not change practice; leaves open its role in pathogenesis or risk stratification.
Objectives: To quantify pancreatic fat content (PFC) in patients with newly diagnosed type 2 diabetes mellitus (T2DM) using proton magnetic resonance spectroscopy. Patients and Methods: Spectra of the pancreatic head, body, and tail were acquired by single-voxel point-resolved spectroscopy sequences on a 3.0-T magnetic resonance scanner in 59 newly diagnosed T2DM patients and 32 non-diabetics (controls). PFC values were calculated and compared between the patients and controls as well as among the head, body, and tail. Correlations were determined between PFC and age, body mass index (BMI), and serum triglyceride (TG) levels. Results: Mean fat fractions did not differ significantly (all Ps > 0.05) across the pancreatic head, body, and tail in either the T2DM group (15.14 ± 7.49%, 17.51 ± 7.74%, and 18.35 ± 7.58%, respectively) or the control group (12.27 ± 7.85%, 15.35 ± 8.53%, and 16.20 ± 10.02%, respectively). Overall, mean PFC values did not differ significantly (P > 0.05) between the T2DM group (16.82 ± 6.16%) and control group (14.56 ± 7.97%). Among T2DM patients, PFC did not correlate with age, TG levels, or BMI (r < 0.15, P > 0.05). Among non-diabetic controls, PFC correlated with BMI (r = 0.362, P = 0.042) and TG levels (r = 0.467, P = 0.007), but not with age (r < 0.15, P > 0.05). Conclusion: PFC in the head, body, and tail are similar for newly diagnosed T2DM patients and non-diabetic persons. PFC does not correlate with age, TG, or BMI in newly diagnosed T2DM patients.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: